Submit Your Article CMED MEACR meeting
An official publication of the Middle-Eastern Association for Cancer Research
Clinical Cancer Investigation Journal
ISSN Print: 2278-1668, Online: 2278-0513
ARTICLE
Year: 2023   |   Volume: 12   |   Issue: 2   |   Page: 18-23     View issue

Prevalence, Types, and Management of Maxillary Sinus Carcinoma: A Systematic Review


, , , , ,
Abstract

As Maxillary Sinus Carcinoma (MSC) is a rare and serious condition and due to the variable treatment modalities, that are seeking to manage it, this systematic review is to assess the prevalence, types, and effectiveness of Chemoradiotherapy (CRT) and Proton Therapy (PBT) in the management of MSC. PubMed, Web of Science, Science Direct, EBSCO, SCOPUS, Wiley, and Cochrane Library were searched. Study articles were screened by title and abstract using Rayyan QCRI then a full-text assessment was implemented. A total of twelve studies with 468 patients and 335 males were included. MSC was prevalent in Japan and SCC was the most common histopathological type of MSC, followed by adenoid cystic carcinoma. PBT is an effective therapeutic modality in managing MSC and offers a promising future in the treatment of head and neck cancer. Proton beam therapy's precise function will become clearer as it becomes more widely used and as clinical research's purview broadens. IMRT and CRT have high survival rates, good local control, and a low risk of recurrence. MSC was prevalent in Japan and SCC was the most common histopathological type of MSC.

Cite this article
Vancouver
Hussain MA, Alanazi TK, Alanazi RL, Alshammari JA, Alshammari AN, Alanazi NTM. Prevalence, Types, and Management of Maxillary Sinus Carcinoma: A Systematic Review. Clin Cancer Investig J. 2023;12(2):18-23. https://doi.org/10.51847/7Eyn3nPGO6
APA
Hussain, M. A., Alanazi, T. K., Alanazi, R. L., Alshammari, J. A., Alshammari, A. N., & Alanazi, N. T. M. (2023). Prevalence, Types, and Management of Maxillary Sinus Carcinoma: A Systematic Review. Clinical Cancer Investigation Journal, 12(2), 18-23. https://doi.org/10.51847/7Eyn3nPGO6

Downloads: 213

Views: 1368
Copyright © 2024 Clinical Cancer Investigation Journal, All rights are reserved and for all open access contents, the Creative Commons licensing terms apply.
Online since 01 December, 2011
Creative Commons License 
ISSN Print: 2278-1668, Online: 2278-0513